Very long term outcomes of atrial fibrillation ablation

医学 烧蚀 心房颤动 导管消融 内科学 心脏病学 外科
作者
Roger A. Winkle,R. Hardwin Mead,Gregory Engel,Jonathan D. Salcedo,Chad Robbins Brodt,Patricia Barberini,Cynthia S. Lebsack,Melissa H. Kong,Shadi Kalantarian,Rob A. Patrawala
出处
期刊:Heart Rhythm [Elsevier BV]
卷期号:20 (5): 680-688 被引量:66
标识
DOI:10.1016/j.hrthm.2023.02.002
摘要

Background Little is known about the very long term durability of atrial fibrillation (AF) ablation. Objective The purpose of this study was to evaluate very long term AF ablation outcomes. Methods We followed 5200 patients undergoing 7145 ablation procedures. We evaluated outcomes after single and multiple ablation procedures for paroxysmal (PAF; 33.6%), persistent (PeAF; 56.4%), and long-standing (LsAF; 9.9%) AF. We compared 3 ablation eras by initial ablation catheter: early (101 patients) using solid big tip (SBT) catheters (October 2003 to December 2005), intermediate (2143 patients) using open irrigated tip (OIT) catheters (December 2005 to August 2016), and contemporary (2956 patients) using contact force (CF) catheters (March 2014 to December 2021). Results AF freedom at 5, 10, and 15 years was as follows: initial ablation: PAF 67.8%, 56.3%, 47.6%; PeAF 46.6%, 35.6%, 26.5%; and LsAF 30.4%, 18.0%, 3.4%; final ablation: PAF 80.3%, 72.6%, 62.5%; PeAF 60.1%, 50.2%, 42.5%; and LsAF 43.4%, 32.0%, 20.6%. For PAF and PeAF, CF ablation procedures were better than OIT ablation procedures (P < .0001) and both were better than SBT ablation procedures (P < .001). LsAF had no outcome improvement over the eras. The 8-year success rate after final ablation for CF, OIT, and SBT catheter eras was as follows: PAF 79.1%, 71.8%, 60.0%; PeAF 55.9%, 50.7%, 38.0%; and LsAF 42.7%, 36.2%, 31.8%. Highest AF recurrence was in the first 2 years, with a 2- to 15-year recurrence of 2%/yr. Success predictors after initial and final ablation procedures were younger age, smaller left atrium, shorter AF duration, male sex, less persistent AF, lower CHA2DS2-VASc score, fewer drugs failed, and more recent catheter era. Conclusion After year 2, there is 2%/yr recurrence rate for all AF types. Ablation success is best in the CF catheter era, intermediate in the OIT era, and worst in the SBT era. Over the ablation eras, outcomes improved for PAF and PeAF but not for LsAF. We should follow patients indefinitely after ablation. We need an understanding of how to better ablate more persistent AF. Little is known about the very long term durability of atrial fibrillation (AF) ablation. The purpose of this study was to evaluate very long term AF ablation outcomes. We followed 5200 patients undergoing 7145 ablation procedures. We evaluated outcomes after single and multiple ablation procedures for paroxysmal (PAF; 33.6%), persistent (PeAF; 56.4%), and long-standing (LsAF; 9.9%) AF. We compared 3 ablation eras by initial ablation catheter: early (101 patients) using solid big tip (SBT) catheters (October 2003 to December 2005), intermediate (2143 patients) using open irrigated tip (OIT) catheters (December 2005 to August 2016), and contemporary (2956 patients) using contact force (CF) catheters (March 2014 to December 2021). AF freedom at 5, 10, and 15 years was as follows: initial ablation: PAF 67.8%, 56.3%, 47.6%; PeAF 46.6%, 35.6%, 26.5%; and LsAF 30.4%, 18.0%, 3.4%; final ablation: PAF 80.3%, 72.6%, 62.5%; PeAF 60.1%, 50.2%, 42.5%; and LsAF 43.4%, 32.0%, 20.6%. For PAF and PeAF, CF ablation procedures were better than OIT ablation procedures (P < .0001) and both were better than SBT ablation procedures (P < .001). LsAF had no outcome improvement over the eras. The 8-year success rate after final ablation for CF, OIT, and SBT catheter eras was as follows: PAF 79.1%, 71.8%, 60.0%; PeAF 55.9%, 50.7%, 38.0%; and LsAF 42.7%, 36.2%, 31.8%. Highest AF recurrence was in the first 2 years, with a 2- to 15-year recurrence of 2%/yr. Success predictors after initial and final ablation procedures were younger age, smaller left atrium, shorter AF duration, male sex, less persistent AF, lower CHA2DS2-VASc score, fewer drugs failed, and more recent catheter era. After year 2, there is 2%/yr recurrence rate for all AF types. Ablation success is best in the CF catheter era, intermediate in the OIT era, and worst in the SBT era. Over the ablation eras, outcomes improved for PAF and PeAF but not for LsAF. We should follow patients indefinitely after ablation. We need an understanding of how to better ablate more persistent AF.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
luyue9406的应助被nnn采纳,获得10
1秒前
今天发CNS了嘛完成签到,获得积分0
1秒前
仙人掌完成签到 ,获得积分10
2秒前
adu完成签到,获得积分10
2秒前
Mokwepa完成签到,获得积分20
2秒前
2秒前
小蘑菇的应助被贾文浩采纳,获得10
3秒前
Song发布了新的文献求助10
3秒前
3秒前
自由妙竹完成签到 ,获得积分10
3秒前
慕青的应助被科研通管家采纳,获得10
3秒前
华仔的应助被害怕的穆采纳,获得10
3秒前
Akim的应助被科研通管家采纳,获得10
3秒前
Maestro_S的应助被iQ采纳,获得10
3秒前
上官若男的应助被科研通管家采纳,获得10
3秒前
蓝天的应助被科研通管家采纳,获得10
4秒前
Owen的应助被xiaoyibabi采纳,获得30
4秒前
123564的应助被科研通管家采纳,获得10
4秒前
明理的帆布鞋完成签到,获得积分10
4秒前
SciGPT的应助被科研通管家采纳,获得10
4秒前
赘婿的应助被科研通管家采纳,获得10
4秒前
刘放发布了新的文献求助10
4秒前
小二郎的应助被科研通管家采纳,获得10
4秒前
123564的应助被科研通管家采纳,获得10
4秒前
4秒前
今后的应助被科研通管家采纳,获得10
5秒前
Akim的应助被科研通管家采纳,获得30
5秒前
5秒前
邂逅时光的应助被科研通管家采纳,获得20
5秒前
orixero的应助被科研通管家采纳,获得20
5秒前
WH的应助被科研通管家采纳,获得10
5秒前
123564的应助被科研通管家采纳,获得10
5秒前
声声慢发布了新的文献求助10
6秒前
6秒前
仙人掌关注了科研通微信公众号
6秒前
6秒前
啦啦啦啦呼完成签到,获得积分10
6秒前
七七完成签到,获得积分10
8秒前
研友_VZG7GZ的应助被LZY采纳,获得10
8秒前
cola完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8168144
求助须知:如何正确求助?哪些是违规求助? 9561199
关于积分的说明 21759542
捐赠科研通 7759434
什么是DOI,文献DOI怎么找? 3429948
关于科研通互助平台的介绍 2553742
邀请新用户注册赠送积分活动 2474463